Semaglutide
Compounded GLP-1 weight management
$525 billed per 3-month shipment · cancel anytime
A weekly GLP-1 receptor agonist prescribed for appetite regulation and sustained weight management, titrated by your Vmed physician.
Final strength is set by your prescribing physician and may differ from your request.
Prescription required. A Vmed physician reviews your intake before anything is dispensed — you're not charged until approval.
Filled by a licensed 503A compounding pharmacy and shipped cold-chain.
What's included
- Weekly subcutaneous dosing
- Physician-managed titration schedule
- Includes syringes, alcohol pads, sharps container and shipping
- Unlimited async messaging with your care team
Protocol details
- Route
- Subcutaneous injection
- Cadence
- Once weekly
- Vial
- 2.5 mg/mL multi-dose vial
- Dispensed by
- 503A compounding pharmacy
- Ships
- Cold-chain, 2-day, refrigerated
Clinical summary
GLP-1 receptor agonist. Slows gastric emptying and acts on hypothalamic appetite centers to reduce caloric intake.
Typical course: 12–16 weeks to maintenance dose, then ongoing under physician review.
Common side effects: Nausea, Constipation, Injection-site reaction, Fatigue.
You may not be eligible if
- · Personal or family history of medullary thyroid carcinoma
- · MEN2 syndrome
- · Pregnant, nursing or planning pregnancy
- · History of pancreatitis
This is not medical advice. Your physician makes the final determination during review. Compounded medications are not FDA-approved.